STOCK TITAN

Baron group trims CareDx (CDNA) stake to 3.75% in latest 13G/A

(Moderate)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

CareDx, Inc. received an amended Schedule 13G from Baron Capital Group, Inc., its affiliates BAMCO, Inc. and Baron Capital Management, Inc., and Ronald Baron regarding ownership of CareDx common stock (CUSIP 14167L103).

The filing reports that Baron Capital Group, Inc. and Ronald Baron each beneficially own 1,937,326 shares of CareDx common stock, representing 3.75% of the class, with shared voting and dispositive power over all such shares and no sole voting or dispositive power. Within this total, BAMCO, Inc. has shared voting and dispositive power over 1,662,887 shares (about 3.22% of the class), and Baron Capital Management, Inc. has shared voting and dispositive power over 274,439 shares (about 0.53% of the class). The filing confirms that this ownership is now 5 percent or less of the outstanding common stock and that advisory clients of BAMCO and BCM have the economic rights to dividends and sale proceeds in their accounts.

Positive

  • None.

Negative

  • None.
Beneficial ownership 1,937,326 shares Shares of CareDx common stock beneficially owned by Baron Capital Group, Inc. and Ronald Baron
Percent of class 3.75 % Percent of CareDx common stock class beneficially owned by Baron Capital Group, Inc. and Ronald Baron
BAMCO shared voting power 1,662,887 shares CareDx shares over which BAMCO, Inc. has shared voting and dispositive power
BCM shared voting power 274,439 shares CareDx shares over which Baron Capital Management, Inc. has shared voting and dispositive power
BAMCO ownership percent 3.22 % Approximate percent of CareDx common stock represented by BAMCO, Inc.’s 1,662,887 shares
BCM ownership percent 0.53 % Approximate percent of CareDx common stock represented by BCM’s 274,439 shares
beneficially owned financial
"Item 4. | Ownership (a) | Amount beneficially owned: 1,937,326"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared voting power financial
"6 | Shared Voting Power 1,662,887.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power financial
"8 | Shared Dispositive Power 1,662,887.00"
parent holding company financial
"Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company"

FAQ

What percentage of CareDx (CDNA) does Baron Capital Group currently report owning?

Baron Capital Group, Inc. and Ronald Baron report beneficial ownership of 1,937,326 CareDx shares, representing 3.75% of the outstanding common stock, with shared voting and dispositive power over all of these shares.

How many CareDx (CDNA) shares are attributed to BAMCO, Inc. in this Schedule 13G/A?

BAMCO, Inc. reports shared voting and dispositive power over 1,662,887 CareDx shares, which represents approximately 3.22% of the company’s common stock, and no sole voting or dispositive power over any shares.

What is Baron Capital Management, Inc.’s reported position in CareDx (CDNA)?

Baron Capital Management, Inc. reports shared voting and dispositive power over 274,439 CareDx shares, representing about 0.53% of the outstanding common stock, with no sole voting or sole dispositive power.

Does the Baron group still hold more than 5% of CareDx (CDNA) common stock?

No. The filing states “Ownership of 5 percent or less of a class”, and reports that Baron Capital Group, Inc. and Ronald Baron beneficially own 3.75% of CareDx’s common stock, below the 5% threshold.

Who has the economic rights to the CareDx (CDNA) shares managed by BAMCO and BCM?

The filing explains that advisory clients of BAMCO and BCM have the right to receive dividends and proceeds from sales of CareDx common stock held in their accounts, not the advisers themselves.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





14167L103

(CUSIP Number)
06/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



BAMCO INC /NY/
Signature:/s/ Ronald Baron
Name/Title:Chairman and CEO
Date:08/14/2026
Baron Capital Group, Inc.
Signature:/s/ Ronald Baron
Name/Title:Chairman and CEO
Date:08/14/2026
Ronald Baron
Signature:/s/ Ronald Baron
Name/Title:Individually
Date:08/14/2026
Baron Capital Management, Inc.
Signature:/s/ Ronald Baron
Name/Title:Chairman and CEO
Date:08/14/2026